Referências

1. Abdel-Qadir H, 2019, EUR HEART J, V40, P3913, DOI 10.1093/eurheartj/ehz460
2. Ainger L E, 1971, J Natl Med Assoc, V63, P261
3. Al-Kindi SG, 2016, MAYO CLIN PROC, V91, P81, DOI 10.1016/j.mayocp.2015.09.009
4. Ala CK, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1225-6
5. Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405
6. Alfano Catherine M, 2016, Am Soc Clin Oncol Educ Book, V35, P241, DOI 10.14694/EDBK_156164
7. Amigoni M, 2010, PEDIATR BLOOD CANCER, V55, P1343, DOI 10.1002/pbc.22637
8. Anker MS, 2019, ESC HEART FAIL, V6, P1140, DOI 10.1002/ehf2.12551
9. Anquetil C, 2018, CIRCULATION, V138, P743, DOI 10.1161/CIRCULATIONAHA.118.035898
10. Armenian SH, 2017, J CLIN ONCOL, V35, P893, DOI 10.1200/JCO.2016.70.5400
11. Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X
12. Ay C, 2017, THROMB HAEMOSTASIS, V117, P219, DOI 10.1160/TH16-08-0615
13. Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116
14. Bendtsen MAF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081736
15. Bonaca MP, 2019, CIRCULATION, V140, P80, DOI 10.1161/CIRCULATIONAHA.118.034497
16. Boursiquot BC, 2017, HYPERTENSION
17. Boyd A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175544
18. Brant LCC, 2017, PB5 BRAS EPIDEMIO S1, V20, P116
19. Brown Allen S, 2018, BMJ OPEN, V8
20. Budolfsen C, 2019, CURR VASC PHARMACOL, V17, P618, DOI 10.2174/1570161117666190130165810
21. Cameron AC, 2016, CAN J CARDIOL, V32, P852, DOI 10.1016/j.cjca.2015.12.023
22. Cardinale D, 2004, CIRCULATION, V109, P2749, DOI 10.1161/01.CIR.0000130926.51766.CC
23. Chang VY, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0696-8
24. Chee CE, 2014, BLOOD, V123, P3972, DOI 10.1182/blood-2014-01-549733
25. Cheng WL, 2016, INT J CARDIOL, V219, P186, DOI 10.1016/j.ijcard.2016.06.009
26. Chong Jun Hua, 2019, Interv Cardiol, V14, P89, DOI 10.15420/icr.2019.12
27. Choueiri TK, 2011, J CLIN ONCOL, V29, P632, DOI 10.1200/JCO.2010.31.9129
28. Chow EJ, 2014, J CLIN ONCOL, V32, P191, DOI 10.1200/JCO.2013.52.6582
29. Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438
30. Correa CR, 2007, J CLIN ONCOL, V25, P3031, DOI 10.1200/JCO.2006.08.6595
31. Costa IBSD, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01471-8
32. Curigliano G, 2020, ANN ONCOL, V31, P171, DOI 10.1016/j.annonc.2019.10.023
33. Curigliano G, 2012, ANN ONCOL, V23, P155, DOI 10.1093/annonc/mds293
34. Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145
35. Desai MY, 2018, JACC-CARDIOVASC IMAG, V11, P1132, DOI 10.1016/j.jcmg.2018.04.028
36. Douxfils J, 2016, JAMA ONCOL, V2, P625, DOI 10.1001/jamaoncol.2015.5932
37. Dummer R, 2018, LANCET ONCOL, V19, P603, DOI 10.1016/S1470-2045(18)30142-6
38. Ewer MS, 2015, NAT REV CARDIOL, V12, P547, DOI 10.1038/nrcardio.2015.65
39. Farge D, 2019, LANCET ONCOL, V20, pE566, DOI 10.1016/S1470-2045(19)30336-5
40. Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026
41. Farrugia F A, 2017, Endocr Regul, V51, P168, DOI 10.1515/enr-2017-0018
42. Ferguson T, 2007, COCHRANE DB SYST REV, V4, P1
43. Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996
44. Ganatra S, 2017, JACC-CARDIOVASC INTE, V10, P2334, DOI 10.1016/j.jcin.2017.06.068
45. Guglin M, 2009, EUROPACE, V11, P1579, DOI 10.1093/europace/eup300
46. Haanen JBAG, 2015, PROG TUMOR RES, V42, P55, DOI 10.1159/000437178
47. Hajjar LA, 2019, 5 GLOBALCARDIO ONCOL
48. Handy CE, 2018, CIRCULATION, V138, P727, DOI 10.1161/CIRCULATIONAHA.118.035516
49. He Q., 2020, JACC CARDIOONCOLOGY, V2, P41
50. Henriksen PA, 2018, HEART, V104, P971, DOI 10.1136/heartjnl-2017-312103
51. Herrmann J, 2016, CIRCULATION, V133, P1272, DOI 10.1161/CIRCULATIONAHA.115.018347
52. Iliescu C, 2016, CATHETER CARDIO INTE, V87, P895, DOI 10.1002/ccd.26375
53. Ito D, 2012, HEART VESSELS, V27, P634, DOI 10.1007/s00380-011-0222-5
54. Jafri M, 2008, ANTI-CANCER DRUG, V19, P927, DOI 10.1097/CAD.0b013e3283100e9c
55. Jaworski C, 2013, J AM COLL CARDIOL, V61, P2319, DOI 10.1016/j.jacc.2013.01.090
56. Jerusalem G, 2019, BREAST CANCER RES TR, V177, P237, DOI 10.1007/s10549-019-05303-y
57. Johnson DB, 2015, JAMA ONCOL, V1, P380, DOI 10.1001/jamaoncol.2015.0565
58. Karabay KO, 2014, J INVASIVE CARDIOL, V26, pE18
59. Kishi S, 2000, INT J HEMATOL, V71, P172
60. Landes U, 2017, CORONARY ARTERY DIS, V28, P5, DOI 10.1097/MCA.0000000000000429
61. Lendvai N, 2015, BLOOD, V126
62. Lenihan DJ, 2016, J CARD FAIL, V22, P465, DOI 10.1016/j.cardfail.2016.03.012
63. Lenihan DJ, 2019, JACC CARDIOONCOLOGY, V1, P256, DOI 10.1016/J.JACCAO.2019.11.007
64. Leong DP, 2019, JACC CARDIOONCOLOGY, V1, P1
65. Li A, 2019, THROMB RES, V173, P158, DOI 10.1016/j.thromres.2018.02.144
66. Li J, 2018, CLIN DRUG INVEST, V38, P1109, DOI 10.1007/s40261-018-0709-2
67. Lidbrink E, 2019, BREAST CANCER RES TR, V174, P187, DOI 10.1007/s10549-018-5058-6
68. LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602
69. Liu Y, 2019, BMC UROL, V19, DOI 10.1186/s12894-019-0481-5
70. Lopez-Fernandez T, 2019, REV ESP CARDIOL, V72, P749, DOI 10.1016/j.rec.2019.03.019
71. Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43
72. Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283
73. Lyon AR, 2020, EUR J HEART FAIL, V22, P1945, DOI 10.1002/ejhf.1920
74. Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2
75. Maverakis E, 2015, ACTA DERM-VENEREOL, V95, P516, DOI 10.2340/00015555-2035
76. McGowan JV, 2017, CARDIOVASC DRUG THER, V31, P63, DOI 10.1007/s10557-016-6711-0
77. Melloni C, 2017, EUR HEART J, V3, P192, DOI 10.1093/ehjqcco/qcx004
78. Meyer T, 2009, J THROMB HAEMOST, V7, P171, DOI 10.1111/j.1538-7836.2008.03212.x
79. Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490
80. Mincu RI, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8890
81. MOSSERI M, 1993, CANCER RES, V53, P3028
82. Nakatsuma K, 2018, EUR HEART J-QUAL CAR, V4, P200, DOI 10.1093/ehjqcco/qcy014
83. Narezkina A, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.119.005910
84. Navi BB, 2017, J AM COLL CARDIOL, V70, P927, DOI 10.1016/j.jacc.2017.06.047
85. Newman JL, 2019, CARDIOVASC PATHOL, V43, DOI 10.1016/j.carpath.2019.107148
86. Rohde LEP, 2018, ARQ BRAS CARDIOL, V111, P436, DOI 10.5935/abc.20180190
87. Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730
88. Periard D, 2007, STROKE, V38, P1636, DOI 10.1161/STROKEAHA.106.479733
89. Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441
90. Ping Z, 2020, OXID MED CELL LONGEV, V2020
91. Porta-Sanchez A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007724
92. Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316
93. Pritchard ER, 2019, J ONCOL PHARM PRACT, V25, P52, DOI 10.1177/1078155217726158
94. Procter M, 2010, J CLIN ONCOL, V28, P3422, DOI 10.1200/JCO.2009.26.0463
95. Qi WX, 2014, BRIT J CLIN PHARMACO, V78, P748, DOI 10.1111/bcp.12387
96. Richards CJ, 2011, J CLIN ONCOL, V29, P3450, DOI 10.1200/JCO.2010.34.4309
97. Russell SD, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.4250.4250
98. Sachidanandam Kamakshi, 2013, J Oncol Pharm Pract, V19, P269, DOI 10.1177/1078155212461022
99. Schrader C, 2005, EUR J MED RES, V10, P498
100. Seferina SC, 2016, ONCOLOGIST, V21, P555, DOI 10.1634/theoncologist.2015-0230
101. Shah K, 2012, J CANCER RES THER, V8, P442, DOI 10.4103/0973-1482.103530
102. Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575
103. Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383
104. Sociedade Brasileira de Cardiologia, 2002, Arq Bras Cardiol, V79 Suppl 5, P7
105. Soultati A, 2012, CANCER TREAT REV, V38, P473, DOI 10.1016/j.ctrv.2011.09.002
106. STOTER G, 1989, J CLIN ONCOL, V7, P1099, DOI 10.1200/JCO.1989.7.8.1099
107. Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513
108. Tamargo J, 2015, DRUG SAFETY, V38, P129, DOI 10.1007/s40264-014-0258-4
109. TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K
110. Tarantini L, 2012, J CARD FAIL, V18, P113, DOI 10.1016/j.cardfail.2011.10.015
111. Thaler J, 2012, HAMOSTASEOLOGIE, V32, P127, DOI 10.5482/ha-1164
112. THYSS A, 1992, ANN ONCOL, V3, P88, DOI 10.1093/oxfordjournals.annonc.a058084
113. Tini G, 2019, INT J CARDIOL, V281, P133, DOI 10.1016/j.ijcard.2019.01.082
114. Totzeck M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006278
115. Urban P, 2019, CIRCULATION, V140, P240, DOI 10.1161/CIRCULATIONAHA.119.040167
116. Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
117. Varricchi G, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2017-000247
118. Vorchheimer David A, 2005, J Fam Pract, VSuppl, pS4
119. Waliany S, 2019, JACC CARDIOONCOL, V1, P24, DOI [10.1016/j.jaccao.2019.08.012, DOI 10.1016/j.jaccao.2019.08.012]
120. Walker AJ, 2013, EUR J CANCER, V49, P1404, DOI 10.1016/j.ejca.2012.10.021
121. Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923
122. Wang HR, 2019, INT J BIOL SCI, V15, P2128, DOI 10.7150/ijbs.35460
123. Wang SY, 2014, BREAST CANCER RES TR, V146, P411, DOI 10.1007/s10549-014-3029-0
124. Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180
125. Yang Q, 2020, ARQ BRAS CARDIOL, V114, P1004, DOI 10.36660/abc.20190201
126. Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050
127. Yuan Cai, 2019, Cardiooncology, V5, P13, DOI 10.1186/s40959-019-0048-3
128. Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211
129. Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919